Inovio Pharmaceuticals Inc vs Kyndryl Holdings Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: Kyndryl Holdings Inc is far larger — about 37× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | KD | |
|---|---|---|
Market Cap | $78.55M | $2.91B |
Sector | Health | Technology |
52-Week High | $2.87 | $33.14 |
52-Week Low | $0.66 | $10.59 |
Enterprise Value | $49.56M | $5.74B |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →